Top Clinical Trials companies in Sweden by EBIT
Sweden
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 27.33 M
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
| 2 |
USD -175.98 K
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
| 3 |
USD -976.14 K
|
Dec. 31, 2023 | USD 0.39 | 2.53% |
|
Sweden |
|
| 4 |
USD -996.97 K
|
Dec. 31, 2023 | USD 0.11 | 1.51% |
|
Sweden |
|
| 5 |
USD -1.57 M
|
Dec. 31, 2023 | USD 0.45 | 23.08% |
|
Sweden |
|
| 6 |
USD -1.69 M
|
Dec. 31, 2023 | USD 0.23 | 11.53% |
|
Sweden |
|
| 7 |
USD -3.52 M
|
Dec. 31, 2023 | USD 0.21 | 0.68% |
|
Sweden |
|
| 8 |
USD -3.66 M
|
Dec. 31, 2023 | USD 0.20 | 1.12% |
|
Sweden |
|
| 9 |
USD -3.67 M
|
Dec. 31, 2023 | USD 1.17 | -3.73% |
|
Sweden |
|
| 10 |
USD -3.94 M
|
Dec. 31, 2023 | USD 0.80 | 0.68% |
|
Sweden |
|
| 11 |
USD -4.07 M
|
Aug. 31, 2024 | USD 0.22 | -6.29% |
|
Sweden |
|
| 12 |
USD -6.40 M
|
Dec. 31, 2023 | USD 0.10 | 0.68% |
|
Sweden |
|
| 13 |
USD -7.02 M
|
Dec. 31, 2023 | USD 0.28 | -7.61% |
|
Sweden |
|
| 14 |
USD -9.99 M
|
Dec. 31, 2023 | USD 0.71 | -2.02% |
|
Sweden |
|
| 15 |
USD -14.80 M
|
Aug. 31, 2024 | USD 1.61 | 0.34% |
|
Sweden |
|
| 16 |
USD -17.53 M
|
Dec. 31, 2023 | USD 0.90 | 9.88% |
|
Sweden |
|
| 17 |
USD -32.52 M
|
Dec. 31, 2023 | USD 2.74 | 1.67% |
|
Sweden |
|
| 18 |
USD -71.59 M
|
Dec. 31, 2023 | USD 2.91 | -2.20% |
|
Sweden |
Frequently Asked Questions
-
Which Clinical Trials company in Sweden has the highest EBIT ?
The Clinical Trials company in Sweden with the highest EBIT is BioArctic AB (publ) (Stockholm Stock Exchange: BIOA-B.ST) at USD 27.33 M.
-
Which Clinical Trials company in Sweden has the lowest EBIT ?
The Clinical Trials company in Sweden with the lowest EBIT is Hansa Biopharma AB (publ) (Stockholm Stock Exchange: HNSA.ST) at USD -71.59 M.
-
What are the top 10 Clinical Trials companies in Sweden by EBIT ?
The top 10 Clinical Trials companies in Sweden by EBIT are BioArctic AB (publ), Corline Biomedical AB, Pila Pharma AB (publ), Aptahem AB (publ), OncoZenge AB (publ), Elicera Therapeutics AB (publ), CombiGene AB (publ), Isofol Medical AB (publ), Lipum AB (publ) and Prostatype Genomics AB (publ).
-
What are the bottom 10 Clinical Trials companies in Sweden by EBIT ?
The bottom 10 Clinical Trials companies in Sweden by EBIT are Hansa Biopharma AB (publ), BioInvent International AB (publ), IRLAB Therapeutics AB (publ), Diamyd Medical AB (publ), Mendus AB (publ), Clinical Laserthermia Systems AB (publ), Kancera AB (publ), NextCell Pharma AB, Prostatype Genomics AB (publ) and Lipum AB (publ).